Valuation: BioGaia AB

Market Cap 11.85B 1.25B 1.07B 1B 917M 1.73B 119B 1.75B 4.61B 60.16B 4.7B 4.59B 199B P/E 2026 *
30.6x
P/E 2027 * 25x
Enterprise Value 11.18B 1.18B 1.01B 948M 866M 1.63B 113B 1.65B 4.35B 56.77B 4.43B 4.34B 188B EV / Sales 2026 *
6.7x
EV / Sales 2027 * 5.97x
Free-Float
80.82%
Yield 2026 *
2.52%
Yield 2027 * 2.73%
1 day-0.64%
1 week+1.22%
Current month+0.69%
3 months-8.85%
6 months+8.48%
Current year+9.60%
1 week 113.8
Extreme 113.8
117.8
1 month 110.3
Extreme 110.3
117.8
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.6
Extreme 48.6
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%+1.22%+16.57%+14.79% 1.25B
+0.61%+2.88%+45.63%+0.39% 83.24B
-0.69%+3.58%-19.85%-35.64% 59.49B
+14.36%+152.27%+526.55%+41.90% 63.41B
+0.76%+3.53%+0.08%+36.18% 52.94B
-1.61%+1.24%+10.39%+168.31% 49.86B
+1.21%+3.87%+61.90%-16.51% 32.62B
+1.36%+5.06%+53.04%+103.13% 26.29B
+9.69%+11.76%+14.67%+215.97% 22.23B
-0.62%+0.39%+61.40%+123.21% 17.22B
Average +0.75%+18.58%+77.04%+65.17% 40.86B
Weighted average by Cap. +0.22%+27.28%+101.20%+48.93%

Financials

2026 *2027 *
Net sales 1.67B 176M 151M 142M 129M 244M 16.81B 246M 650M 8.48B 662M 647M 28.08B 1.88B 198M 170M 159M 145M 274M 18.89B 277M 731M 9.53B 744M 728M 31.56B
Net income 387M 40.86M 35.01M 32.81M 29.97M 56.56M 3.9B 57.12M 151M 1.97B 153M 150M 6.51B 474M 50.05M 42.89M 40.18M 36.71M 69.27M 4.77B 69.96M 185M 2.41B 188M 184M 7.97B
Net Debt -667M -70.43M -60.35M -56.55M -51.65M -97.48M -6.71B -98.44M -260M -3.39B -264M -259M -11.22B -646M -68.16M -58.4M -54.72M -49.99M -94.34M -6.5B -95.27M -251M -3.28B -256M -250M -10.86B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
26/08/26 SEK 116.50 -0.51% 642,807
25/08/26 SEK 117.10 +0.69% 119,517
24/08/26 SEK 116.30 +0.35% 74,183
21/08/26 SEK 115.90 +1.05% 138,106
20/08/26 SEK 114.70 -0.26% 149,864
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
117.10SEK
Average target price
152.50SEK
Spread / Average Target
+30.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock